Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19
Under a Creative Commons license
open access
Keywords
SARS-CoV-2
Side effects
Drug repositioning
Small scale genetic signature
Coronavirus
Machine learning
Cited by (0)
© 2022 The Authors. Published by Elsevier Ltd.